Lotensin Hct

   
Google
 
Web NewDrugInformation.com

Lotensin Hct


Drug - Lotensin Hct
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Benazepril Hydrochloride; Hydrochlorothiazide
Multiple ingredients are in alphabetical order.

Strength - 20MG;25MG
The potency of the active ingredient(s), Benazepril Hydrochloride; Hydrochlorothiazide. May repeat for multiple part products.

Applicant - NOVARTIS
The firm name holding legal responsibility for Lotensin Hct. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020033
The FDA assigned number to Lotensin Hct. Format is nnnnnn.

Product Number - 003
The FDA assigned number to identify Lotensin Hct. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - May 19, 1992
The date Lotensin Hct was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Lotensin Hct. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Lotensin Hct is in. Format is RX, OTC, DISCN.

Applicant Full Name - Novartis Pharmaceuticals Corp
The full name of the firm holding legal responsibility for the new application of Lotensin Hct.

Lotensin Hct